Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Pfizer's Humira biosimilar secures FDA approval due to launch in 2023

$
0
0
Pfizer has confirmed the FDA approval of Abrilada adalimumabafzb its biosimilar version of AbbVies Humira the worlds bestselling drug Pfizers therapy is now authorised for use in all approved indications of its reference product including rheumatoid arth...

Viewing all articles
Browse latest Browse all 2985

Trending Articles